Xiang Li, Wolfgang Bauer, Ina Israel, Michael C Kreissl, Johannes Weirather, Dominik Richter, Elisabeth Bauer, Volker Herold, Peter Jakob, Andreas Buck, Stefan Frantz, Samuel Samnick
Index: Arterioscler. Thromb. Vasc. Biol. 34(8) , 1661-7, (2014)
Full Text: HTML
Nuclear imaging of active plaques still remains challenging. Advanced atherosclerotic plaques have a strong expression of P-selectin by the endothelium overlying active atherosclerotic plaques, but not on the endothelium overlying inactive fibrous plaques. We proposed a new approach for noninvasive in vivo characterization of P-selectin on active plaques based on (68)Ga-Fucoidan, which is a polysaccharidic ligand of P-selectin with a nanomolar affinity.(68)Ga-Fucoidan was tested for its potential to discriminate vulnerable plaques on apolipoprotein E-deficient mice receiving a high cholesterol diet by positron emission tomography and in correlation with 17.6T MRI. Furthermore, (68)Ga-Fucoidan was evaluated on endothelial cells in vitro and ex vivo on active plaques using autoradiography. The cellular uptake rate was increased ≈2-fold by lipopolysaccharide induction. Interestingly, on autoradiography, more intensive tracer accumulation at active plaques with thin fibrous caps and high-density foam cells were observed in comparison with a weaker focal uptake in inactive fibrous plaque segments (R=1.7±0.3; P<0.05) and fatty streaks (R=2.4±0.4; P<0.01). Strong uptake of radiotracer colocalized with increased P-selectin expression and high-density macrophage. Focal vascular uptake (mean of target to background ratio=5.1±0.8) of (68)Ga-Fucoidan was detected in all apolipoprotein E-deficient mice. Anatomic structures of plaque were confirmed by 17.6T MRI. The autoradiography showed a good agreement of (68)Ga-Fucoidan uptake with positron emission tomography.Our data suggest that (68)Ga-Fucoidan represents a versatile imaging biomarker for P-selectin with the potential to specifically detect P-selectin expression using positron emission tomography and to discriminate vulnerable plaques in vivo.© 2014 American Heart Association, Inc.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Fucoidan
CAS:9072-19-9 |
C7H14O7S |
Antiproliferative activity of fucan nanogel.
2012-09-01 [Mar. Drugs 10(9) , 2002-22, (2012)] |
Modulation of platelet aggregation-related eicosanoid produc...
2013-09-14 [Br. J. Nutr. 110(5) , 880-90, (2013)] |
Fucoidan directly regulates the chemotaxis of canine periphe...
2013-01-15 [Vet. Immunol. Immunopathol. 151(1-2) , 124-31, (2013)] |
Effect of fucoidan extracted from mozuku on experimental car...
2012-11-01 [Mar. Drugs 10(11) , 2560-70, (2012)] |
RhoG protein regulates glycoprotein VI-Fc receptor γ-chain c...
2013-11-22 [J. Biol. Chem. 288(47) , 34230-8, (2013)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved